-+ 0.00%
-+ 0.00%
-+ 0.00%

Dermata Therapeutics FY2025 net loss narrows 38.5% to $7.6 million; cash and cash equivalents climb 138% to $8 million

Reuters·03/26/2026 21:17:18

Please log in to view news